Clinical trial
Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
Recruiting now · Not applicable · 1 countries · Registry ID NCT07175155
What this study is about
Hypoxaemia during sedated gastrointestinal endoscopy exceeds 40 % in morbidly obese (BMI ≥ 35 kg m-²) patients. High-flow nasal cannula alone often fails because of persistent airway collapse. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management.The purpose of this study is to investigate whether the combination of the COMBO Endoscopy Oropharyngeal Airway and High-Flow Nasal Cannula oxygenation reduces the incidence of hypoxemia in this population.
Basic eligibility
Full registry criteria
Treatments and study arms
COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation
Using the COMBO endoscopy oropharyngeal airway with High-Flow Nasal Cannula Oxygenation in sedated gastrointestinal endoscopy for morbidly obese patients
High-Flow Nasal Cannula Oxygenation
In this group, patients use high-flow nasal cannula oxygenation
Primary outcomes
75% ≤ SpO2 \< 90% for \<60 s
Study locations
5 locations were listed when this page was built. The first 40 are shown.